LinkGevity in the news
Browse a curated feed of milestones, research updates, and media coverage
The Times highlights LinkGevity’s aim to protect organs from age-related degeneration
Covering new preclinical data, The Times describes how LinkGevity’s Anti-Necrotic™ protects cells by blocking calcium influx, with independent labs replicating the results and early studies suggesting cross-species relevance, reinforcing hopes that kidney trials could pave the way for broader applications in cardiovascular, neurodegenerative and metabolic disease.
LinkGevity features in Financial Times
LinkGevity was featured as part of the five-part series on companies focused on anti-ageing therapies. The article captures how our work on Anti-Necrotic™ technology is opening new frontiers in medicine and longevity science. This recognition reflects the progress, collaboration, and vision of our amazing team and partners.
Science Communication
Stay informed about the latest peer-reviewed articles, talks, and other public communications of our groundbreaking research and discoveries.
Decoding Ageing at The Royal Institution
Dr. Kern delves into the ageing process and opportunities to slow it down
LinkGevity on BBC News Podcast
BBC News AI Decoded Podcast episode featuring our sister founders
Research on future GLP-1-type systemic drugs
A new paper offers a roadmap to designing system-level medicines
